Role of Aspergillus lentulus 14-α sterol demethylase (Cyp51A) in azole drug susceptibility

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5459-5468

  Mellado, Emilia ^a   Alcazar Fuoli, Laura ^a,b   Cuenca Estrella, Manuel ^a   Rodriguez Tudela, Juan L ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPERGILLUS LENTULUS STEROL 14ALPHA DEMETHYLASE; FLUCONAZOLE; FUNGAL PROTEIN; ITRACONAZOLE; POSACONAZOLE; PYRROLE DERIVATIVE; STEROL 14ALPHA DEMETHYLASE; UNCLASSIFIED DRUG; VORICONAZOLE;

AMINO ACID SEQUENCE; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; ASPERGILLUS LENTULUS; GENE DELETION; GENE INACTIVATION; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; WILD TYPE;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLUS; AZOLES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; GENE DELETION; HUMANS; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; PULMONARY ASPERGILLOSIS; STEROL 14-DEMETHYLASE; VIRULENCE;

EID: 81555206790     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05178-11     Document Type: Article

References (50)

1. Aberkane, A., et al. 2002. Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J. Antimicrob. Chemother. 50:719-722. (Pubitemid 35331690)
2. Alcazar-Fuoli, L., I. Cuesta, M. Cuenca-Estrella, J. L. Rodriguez-Tudela, and E. Mellado. 2011. Three dimensional models of 14-α sterol demethylase (Cyp51A) from Aspergillus lentulus and A. fumigatus: An insight into differences in voriconazole interaction. Int. J. Antimicrob. Agents 38:426-434.
3. Alcazar-Fuoli, L., E. Mellado, A. Alastruey-Izquierdo, M. Cuenca-Estrella, and J. L. Rodriguez-Tudela. 2008. Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification. Antimicrob. Agents Chemother. 52:1244-1251. (Pubitemid 351521983)
4. Alhambra, A., et al. 2008. Isolation of Aspergillus lentulus in Spain from a critically ill patient with chronic obstructive pulmonary disease. Rev. Iberoam. Micol. 25:246-249.
5. Balajee, S. A., et al. 2005. Mistaken identity: Neosartorya pseudofischeri and its anamorph masquerading as Aspergillus fumigatus. J. Clin. Microbiol. 43: 5996-5999. (Pubitemid 43100650)
6. Balajee, S. A., J. L. Gribskov, E. Hanley, D. Nickle, and K. A. Marr. 2005. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot. Cell 4:625-632. (Pubitemid 40383765)
7. Balajee, S. A., et al. 2009. Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network. J. Clin. Microbiol. 47:3138-3141.
8. Balajee, S. A., D. Nickle, J. Varga, and K. A. Marr. 2006. Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping. Eukaryot. Cell 5:1705-1712. (Pubitemid 44622598)
9. Balajee, S. A., M. Weaver, A. Imhof, J. Gribskov, and K. A. Marr. 2004. Aspergillus fumigatus variant with decreased susceptibility to multiple anti-fungals. Antimicrob. Agents Chemother. 48:1197-1203. (Pubitemid 38405473)
10. Bueid, A., et al. 2010. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J. Antimicrob. Chemother. 65:2116-2118.
11. Bulpa, P., A. Dive, and Y. Sibille. 2007. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 30:782-800. (Pubitemid 351194841)
12. Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, M. J. Buitrago, A. Monzon, and J. L. Rodriguez-Tudela. 2006. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob. Agents Chemother. 50:917-921. (Pubitemid 43327795)
13. da Silva Ferreira, M. E., et al. 2004. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob. Agents Chemother. 48:4405-4413.
14. KU80 mutant deficient for nonhomologous end joining is a powerful tool for analyzing pathogenicity in Aspergillus fumigatus. Eukaryot. Cell 5:207-211.
15. Denning, D. W., et al. 2011. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin. Infect. Dis. 52:1123-1129.
16. Diaz-Guerra, T. M., E. Mellado, M. Cuenca-Estrella, and J. L. Rodriguez-Tudela. 2003. A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 47:1120-1124.
17. Dimopoulos, G., et al. 2003. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J. Chemother. 15:71-75. (Pubitemid 36349895)
18. Ghannoum, M. A., and L. B. Rice. 1999. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12:501-517. (Pubitemid 29484744)
19. Higgins, D. G., and P. M. Sharp. 1988. CLUSTAL: a package for performing multiple sequence alignments on a microcomputer. Gene 73:237-244. (Pubitemid 19033800)
20. Holden, D. W., J. W. Kronstad, and S. A. Leong. 1989. Mutation in a heat regulated hsp70 gene of Ustilago maydis. EMBO J. 8:1927-1934. (Pubitemid 19273516)
21. Howard, S. J., et al. 2009. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg. Infect. Dis. 15:1068-1076.
22. Kontoyiannis, D. P., et al. 2010. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database. Clin. Infect. Dis. 50:1091-1100.
23. Lamarre, C., O. Ibrahim-Granet, C. Du, R. Calderone, and J. P. Latgé. 2007. Characterization of the SKN7 ortholog of Aspergillus fumigatus. Fungal Genet. Biol. 44:682-690. (Pubitemid 46809821)
24. Lionakis, M. S., et al. 2005. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn. Microbiol. Infect. Dis. 52:15-20. (Pubitemid 40692735)
25. Malani, A. N., and C. A. Kauffman. 2007. Changing epidemiology of rare mould infections: implications for therapy. Drugs 67:1803-1812. (Pubitemid 47347394)
26. Mann, P. A., et al. 2003. Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase. Antimicrob. Agents Chemother. 47:577-581. (Pubitemid 36158085)
27. Manoharlal, R., N. A. Gaur, S. L. Panwar, J. Morschhäuser, and R. Prasad. 2008. Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans. Antimicrob. Agents Chemother. 52:1481-1492. (Pubitemid 351522015)
28. Mellado, E., et al. 2006. New resistance mechanisms to azole drugs in Aspergillus fumigatus and emergence of antifungal drugs-resistant A. fumigatus atypical strains. Med. Mycol. 44(Suppl.):367-371. (Pubitemid 44524129)
29. Mellado, E., T. M. Diaz-Guerra, M. Cuenca-Estrella, and J. L. Rodriguez-Tudela. 2001. Identification of two different 14-alpha sterol demethylaserelated genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J. Clin. Microbiol. 39:2431-2438. (Pubitemid 32606215)
30. Mellado, E., G. Garcia-Effron, L. Alcazar-Fuoli, M. Cuenca-Estrella, and J. L. Rodriguez-Tudela. 2004. Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob. Agents Chemother. 48:2747-2750. (Pubitemid 38823458)
31. Mellado, E., et al. 2005. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob. Agents Chemother. 49:2536-2538. (Pubitemid 40734499)
32. Mellado, E., et al. 2007. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob. Agents Chemother. 51:1897-1904. (Pubitemid 46903071)
33. Montenegro, G., et al. 2009. Phenotypic and genotypic characterization of Aspergillus lentulus and Aspergillus fumigatus isolates in a patient with probable invasive aspergillosis. J. Med. Microbiol. 58:391-395.
34. Nascimento, A. M., et al. 2003. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob. Agents Chemother. 47:1719-1726. (Pubitemid 36548560)
35. Pasqualotto, A. C., M. O. Xavier, H. F. Andreolla, and R. Linden. 2010. Voriconazole therapeutic drug monitoring: focus on safety. Expert Opin. Drug Safety 9:125-137.
36. Rodriguez-Tudela, J. L., et al. 2008. Epidemiological cut-offs and cross resistance to azole drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 52:2468-2472. (Pubitemid 351915677)
37. Rodriguez-Tudela, J. L., et al. 2008. EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). Clin. Microbiol. Infect. 14: 982-984.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis 1989. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
39. Schmittgen, T. D., and K. J. Livak. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1118.
40. Snelders, E., et al. 2008. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 5:e219.
41. Staab, J. F., J. N. Kahn, and K. A. Marr. 2010. Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent. Antimicrob. Agents Chemother. 54:4992-4998.
42. Symoens, F., et al. 2010. Unusual Aspergillus species in patients with cystic fibrosis. Med. Mycol. 48:S10-S16.
43. Tang, C. M., J. Cohen, and D. W. Holden. 1992. An Aspergillus fumigatus alkaline protease mutant constructed by gene disruption is deficient in extracellular elastase activity. Mol. Microbiol. 6:1663-1671.
44. Tang, C. M., J. Cohen, T. Krausz, S. Van Noorden, and D. W. Holden. 1993. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect. Immun. 61:1650-1656. (Pubitemid 23145857)
45. Van Der Linden, J. W., A. Warris, and P. E. Verweij. 2011. Aspergillus species intrinsically resistant to antifungal agents. Med. Mycol. 49:S82-S89.
46. Verweij, P. E., S. J. Howard, W. J. Melchers, and D. W. Denning. 2009. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist. Updat. 12:141-147.
47. Verweij, P. E., E. Mellado, and W. J. Melchers. 2007. Multiple-triazole-resistant aspergillosis. N. Engl. J. Med. 356:1481-1483.
48. Walsh, T. J., et al. 2007. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin. Infect. Dis. 44:2-12. (Pubitemid 44968977)
49. Wurch, T., F. Lestienne, and P. J. Pauwels. 1998. A modified overlap extension PCR method to create chimeric genes in the absence of restriction enzymes. Biotechnol. Techniques 12:653-657. (Pubitemid 28456279)
50. Xiao, L., et al. 2004. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob. Agents Chemother. 48:568-574 (Pubitemid 38141718)